⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL344277 | 0.82 | — | — | |
| SCHEMBL3035752 | 0.81 | TSHR (0.46) | — | |
| SCHEMBL696904 | 0.80 | ALOX5 (0.31) | — | |
| SCHEMBL10772047 | 0.79 | — | — | |
| SCHEMBL4390936 | 0.78 | — | — | |
| SCHEMBL6472544 | 0.77 | — | — | |
| SCHEMBL1439310 | 0.77 | TSHR (0.42) | — | |
| SCHEMBL6890814 | 0.77 | — | — | |
| SCHEMBL1361342 | 0.77 | MAPT (0.33) | — | |
| SCHEMBL697823 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3641 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4397366-A2 | GLYCYRRHETINIC ACID DERIVATIVES FOR TREATING HYPERKALEMIA | Ardelyx, Inc. (US) | 2024-07-10 | — | — | EP | claimed |
| US-11768319-B2 | Glycyrrhetinic acid derivatives for treating hyperkalemia | ARDELYX, INC. (US) | 2023-09-26 | — | — | US | claimed |
| US-20230273354-A1 | GLYCYRRHETINIC ACID DERIVATIVES FOR TREATING HYPERKALEMIA | ARDELYX, INC. (US) | 2023-08-31 | — | — | US | claimed |
| US-11234966-B2 | C5-substituted carbapenem antibiotics, compositions containing such compounds, and methods of use in treatment of mycobacterium tuberculosis and non-tubercular mycobacteria | SOUTHERN METHODIST UNIVERSITY (US) | 2022-02-01 | — | — | US | claimed |
| US-20210163524-A1 | GLYCYRRHETINIC ACID DERIVATIVES FOR TREATING HYPERKALEMIA | ARDELYX, INC. (US) | 2021-06-03 | — | — | US | claimed |
| EP-3360877-B1 | 1,6- DIAZABICYCLO [3,2,1]OCTAN- 7- ONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS | WOCKHARDT LTD (IN) | 2021-02-17 | — | — | EP | claimed |
| EP-2642992-B1 | COMPOUNDS AND THEIR USE | ALLECRA THERAPEUTICS GMBH (DE) | 2020-11-25 | — | — | EP | claimed |
| US-20200339582-A1 | Atypical Carbapenem Antibiotics with Improved Activity Against Carbapenemase-Producing Acinetobacter baumannii | BUYNAK JOHN (US) | 2020-10-29 | — | — | US | claimed |
| US-20200281894-A1 | C5-SUBSTITUTED CARBAPENEM ANTIBIOTICS, COMPOSITIONS CONTAINING SUCH COMPOUNDS, AND METHODS OF USE IN TREATMENT OF MYCOBACTERIUM TUBERCULOSIS AND NON-TUBERCULAR MYCOBACTERIA | UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. | 2020-09-10 | — | — | US | claimed |
| US-10711010-B2 | Hydroxyester derivatives, a process for their preparation and pharmaceutical compositions containing them | LES LABORATORIES SERVIER (FR) | 2020-07-14 | — | — | US | claimed |
| WO-1992001696-A1 | CEPHALOSPORINS AND HOMOLOGUES, PREPARATIONS AND PHARMACEUTICAL COMPOSITIONS | BEECHAM GROUP PLC (GB) | 1992-02-06 | — | — | WO | claimed |
| US-5068232-A | Bactericides | AMERICAN CYANAMID COMPANY (US) | 1991-11-26 | — | — | US | claimed |
| US-5036063-A | Penem derivatives | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-07-30 | — | — | US | claimed |
| EP-0373388-A2 | Penem derivatives and process for their preparation | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-06-20 | — | — | EP | claimed |
| EP-0307872-A2 | Esters of amino-acids, process for their preparation, medicaments containing them and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-03-22 | — | — | EP | claimed |
| US-4731362-A | Alkylcarbamoyloxymethylcephem compounds | SHIONOGI & CO., LTD. (JP) | 1988-03-15 | — | — | US | claimed |
| EP-0197018-A1 | 16,17-Acetal-substituted androstane-17-beta-carboxylic-acid esters, process for their preparation and pharmaceutical compound containing them | Aktiebolaget Draco (SE) | 1986-10-08 | — | — | EP | claimed |
| EP-0050805-B1 | BETA-LACTAMS, INTERMEDIATES AND PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1985-07-24 | — | — | EP | claimed |
| US-4376770-A | OXACEPHALOSPORINS | SHIONOGI & CO., LTD. (JP) | 1983-03-15 | — | — | US | claimed |
| US-4292428-A | ANTIBIOTICS; EASILY HYDROLYZED ESTERS AND ETHERS | HOFFMANN-LA ROCHE INC. (US) | 1981-09-29 | — | — | US | claimed |